Ana Lúcia Costa

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases

I. Vendrell, S. Casimiro, L. Costa, 2019, International journal of molecular sciences.

Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development

D. Sobral, R. Vijayaraghavan, Shile Zhang, 2022, Communications Biology.

HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome

R. Vijayaraghavan, C. Garbutt, A. Wise, 2021, npj Genomic Medicine.

Landscape of Current Targeted Therapies for Advanced Colorectal Cancer

L. Costa, Marta Martins, A. Mansinho, 2020, Colorectal Cancer.

Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization

M. Lopes, S. Vinga, R. Vijayaraghavan, 2023, BMC Bioinformatics.

The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012

I. Fernandes, L. Costa, T. Amaral, 2013, ISRN hepatology.

Prevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid Tumors

L. Costa, T. Pacheco, A. Quintela, 2015, BioMed research international.

Pretreatment hemoglobin level as a prognostic factor in patients with locally advanced head and neck squamous cell carcinoma.

L. Costa, A. Florindo, A. Abrunhosa-Branquinho, 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Activation of PI3K/AKT/mTOR pathway in ER+ breast cancer: Analysis of paired primary and metastatic tumor samples.

A. Lipton, L. Costa, K. Leitzel, 2015 .